Latest & greatest articles for headache

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on headache or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on headache and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for headache

121. Does Bed Rest Prevent Post-Lumbar Puncture Headache?

Does Bed Rest Prevent Post-Lumbar Puncture Headache? DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Annals of Emergency Medicine Systematic Review Snapshots2011

122. Prophylactic Etoricoxib Is Effective in Preventing Yom Kippur Headache: A Placebo-Controlled Double-Blind and Randomized Trial of Prophylaxis for Ritual Fasting Headache

Prophylactic Etoricoxib Is Effective in Preventing Yom Kippur Headache: A Placebo-Controlled Double-Blind and Randomized Trial of Prophylaxis for Ritual Fasting Headache 20039959 2010 11 03 2013 07 22 2016 11 25 1526-4610 50 8 2010 Sep Headache Headache Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. 1328-34 10.1111/j.1526-4610.2009.01587.x Religious fasting is associated (...) with headache. This has been documented as "Yom Kippur Headache" and "First-of-Ramadan Headache." Rofecoxib (Vioxx®), a cyclooxygenase-2 (Cox-2) inhibitor with a 17-hour half-life, has been shown to be effective in preventing fasting headache when taken just prior to the 25-hour Yom Kippur fast. Unfortunately for fasters rofecoxib is no longer available. We hypothesized that etoricoxib, another Cox-2 inhibitor with a longer half-life, would also be effective in preventing fasting headache. We performed

EvidenceUpdates2010

123. High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study.

High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. OBJECTIVE: To identify high risk clinical characteristics for subarachnoid haemorrhage in neurologically intact patients with headache. DESIGN: Multicentre prospective cohort study over five years. SETTING: Six university affiliated tertiary care teaching hospitals in Canada. Data collected from November 2000 until November 2005. PARTICIPANTS: Neurologically intact adults (...) with a non-traumatic headache peaking within an hour. MAIN OUTCOME MEASURES: Subarachnoid haemorrhage, as defined by any of subarachnoid haemorrhage on computed tomography of the head, xanthochromia in the cerebrospinal fluid, or red blood cells in the final sample of cerebrospinal fluid with positive results on angiography. Physicians completed data collection forms before investigations. RESULTS: In the 1999 patients enrolled there were 130 cases of subarachnoid haemorrhage. Mean (range) age was 43.4

BMJ2010 Full Text: Link to full Text with Trip Pro

124. Cosyntropin for prophylaxis against postdural puncture headache after accidental dural puncture

Cosyntropin for prophylaxis against postdural puncture headache after accidental dural puncture 20613476 2010 07 26 2010 08 31 2010 07 26 1528-1175 113 2 2010 Aug Anesthesiology Anesthesiology Cosyntropin for prophylaxis against postdural puncture headache after accidental dural puncture. 413-20 10.1097/ALN.0b013e3181dfd424 The aim of the current study was to investigate the effect of administration of cosyntropin after accidental dural puncture (ADP) on the incidence of postdural puncture (...) headache (PDPH) and the need for therapeutic epidural blood patch (EBP). Ninety parturients who suffered an ADP were studied. After delivery, patients were randomly assigned to one of two equal-sized groups. In group I (cosyntropin group), patients received cosyntropin in a dose of 1 mg intravenously. In group II (control group), patients received an equal volume of normal saline. Fifteen patients (33%) in the cosyntropin group suffered from PDPH, compared with 31 patients (68.9%) in the control group

EvidenceUpdates2010

125. Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan

Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan 20303198 2010 07 12 2010 08 05 2016 11 22 1097-6760 56 1 2010 Jul Annals of emergency medicine Ann Emerg Med Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan. 7-17 10.1016/j.annemergmed.2010.02.005 Multiple parenteral medications are used to treat migraine and other acute primary headaches (...) in the emergency department (ED). Regardless of specific headache diagnosis, no medication eliminates the frequent recurrence of primary headache after ED discharge. It is uncertain which medication primary headache patients should be given on discharge from an ED. The aim of this study is to compare the efficacy of oral sumatriptan with naproxen for treatment of post-ED recurrent primary headache. This was a randomized, double-blind efficacy trial. We randomized patients to either naproxen 500

EvidenceUpdates2010 Full Text: Link to full Text with Trip Pro

126. Caffeine in the treatment of post lumbar puncture headache

Caffeine in the treatment of post lumbar puncture headache BestBets: Caffeine in the treatment of post lumbar puncture headache Caffeine in the treatment of post lumbar puncture headache Report By: Martin Duff - Specialist Registrar in Emergency Medicine Search checked by S Elkhodair - Consultant Emergency Medicine Institution: St Georges Hospital NHS Trust, UK Date Submitted: 9th July 2010 Last Modified: 9th July 2010 Status: Green (complete) Three Part Question Can [caffeine] be used in [ED (...) patients with post lumbar puncture headache] as part of [effective control of symptoms]? Clinical Scenario You performed an LP on a middle aged male patient and you were very pleased with the negative result. Forty-eight hours later the same patient returns with disabling headache associated with nausea and vomiting. After your clinical assessment it all fits into a post lumbar puncture headache (PLPH). You decide upon conservative management as a blood patch requires real expertise. You think you saw

BestBETS2010

127. Caffeine in the prophylaxis of post lumbar puncture headache.

Caffeine in the prophylaxis of post lumbar puncture headache. BestBets: Caffeine in the prophylaxis of post lumbar puncture headache. Caffeine in the prophylaxis of post lumbar puncture headache. Report By: Martin Duff - Specialist Registrar in Emergency Medicine Search checked by S. Elkhodair - Consultant Emergency Medicine Institution: St Georges Hospital NHS Trust Date Submitted: 1st June 2007 Date Completed: 9th July 2010 Last Modified: 9th July 2010 Status: Green (complete) Three Part (...) Question Can [caffeine] be used in [in patients undergoing lumbar puncture] as [prophylaxis for headache]? Clinical Scenario You are preparing to perform a lumbar puncture to exclude subarachnoid haemorrhage. The patient is concerned that he might develop a worse headache after the lumbar puncture as his father has experienced in the past. He asks you if there is anything you could do to ensure this does not happen. You are using the smallest available LP needle, and you wonder whether prophylactic

BestBETS2010

128. Prophylaxis of migraine headache

Prophylaxis of migraine headache 20159899 2010 04 20 2010 09 16 2017 02 20 1488-2329 182 7 2010 Apr 20 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Prophylaxis of migraine headache. E269-76 10.1503/cmaj.081657 Pringsheim Tamara T Department of Clinical Neurosciences, University of Calgary, Calgary Headache Assessment and Management Program, Foothills Medical Centre, 1403-29th St. NW, Calgary AB T2N 2T9. tmprings@ucalgary.ca Davenport W Jeptha (...) WJ Becker Werner J WJ eng Journal Article Meta-Analysis Review 2010 02 16 Canada CMAJ 9711805 0820-3946 0 Anticonvulsants 0 Antidepressive Agents 0 Antihypertensive Agents 0 Neuromuscular Agents 0 Vitamins 0BY8440V3N Pizotyline EC 3.4.24.69 Botulinum Toxins, Type A R7PLA2DM0J Flunarizine AIM IM Ann Intern Med. 2010 Nov 16;153(10):JC5-4 21079211 Acta Neurol Scand. 1977 Jul;56(1):17-28 327746 Headache. 2007 Apr;47(4):486-99 17445098 Am J Ther. 2006 May-Jun;13(3):183-7 16772757 Cephalalgia. 1991 Dec

EvidenceUpdates2010 Full Text: Link to full Text with Trip Pro

129. Lack of Efficacy of Manual Therapy in Children and Adolescents With Suspected Cervicogenic Headache: Results of a Prospective, Randomized, Placebo-Controlled, and Blinded Trial

Lack of Efficacy of Manual Therapy in Children and Adolescents With Suspected Cervicogenic Headache: Results of a Prospective, Randomized, Placebo-Controlled, and Blinded Trial 19845788 2010 05 11 2010 08 18 2011 01 19 1526-4610 50 2 2010 Feb Headache Headache Lack of efficacy of manual therapy in children and adolescents with suspected cervicogenic headache: results of a prospective, randomized, placebo-controlled, and blinded trial. 224-30 10.1111/j.1526-4610.2009.01550.x Clinical trials (...) concerning cervical spine manipulation and mobilization in children and adolescents with cervicogenic headache are lacking. We performed a multicenter, prospective, randomized, placebo-controlled, and blinded trial in 52 children and adolescents (21 boys, 31 girls) aged 7-15. After prospective baseline documentation for 2 months patients were either assigned to placebo or true manipulation with another 2-month follow-up. Main outcome measures were defined as: percentage of days with headache, total

EvidenceUpdates2010

130. The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial

The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial 19923528 2009 11 20 2009 12 03 2013 11 21 1526-7598 109 6 2009 Dec Anesthesia and analgesia Anesth. Analg. The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial. 1972-80 10.1213/ANE.0b013e3181be3f86 On the basis of a small number of case studies, IV propofol has (...) been advocated for the treatment of chronic daily headache (CDH). There has been no randomized controlled trial of this therapy. Our objective in this randomized, double-blind, placebo-controlled trial was to determine whether a single IV dose of propofol 2.4 mg/kg results in clinically significant reduction in disability or pain in CDH for the next 30 days. Eligible adults with CDH received either active treatment with IV propofol infusion (n = 20) or active placebo of IV midazolam (n = 20

EvidenceUpdates2010

131. Acute and preventive pharmacologic treatment of cluster headache

Acute and preventive pharmacologic treatment of cluster headache Acute and preventive pharmacologic treatment of cluster headache Acute and preventive pharmacologic treatment of cluster headache Francis GJ, Becker WJ, Pringsheim TM CRD summary The authors recommend offering subcutaneous sumatriptan 6mg, intranasal zolmitriptan 5mg and 10mg and 100% oxygen for treatment of cluster headaches. Preventive therapies that should or may be considered were recommended in the review. Given the potential (...) for missed data and the limited evidence for the different treatments, the authors’ recommendations should be interpreted with caution. Authors' objectives To assess the effectiveness of treatments for the prevention of cluster headache attacks or reduction in headache severity. Searching MEDLINE (from 1950) and EMBASE (from 1980) were searched to June 2009. An updated search of MEDLINE was undertaken to February 2010. The full MEDLINE search strategy was reported in an on-line appendix. Study selection

DARE.2010

132. Botulinum toxin treatment for primary headache

Botulinum toxin treatment for primary headache Botulinum toxin treatment for primary headache Botulinum toxin treatment for primary headache Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Report may be purchased from Citation Botulinum toxin treatment for primary headache. Lansdale: HAYES, Inc.. 2010 Authors' conclusions Botulinum toxin (BTX), a neurotoxin produced (...) by the bacterium Clostridium (C.) botulinum, is a prophylactic or acute treatment for chronic or recurrent headache. The theoretical basis of its action is that BTX relieves muscle tension by blocking the release of the neurotransmitter acetylcholine at the neuromuscular junction, thereby interfering with nerve transmission and blocking subsequent muscle contraction. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Botulinum Toxin Type A; Headache Disorders, Primarys; Migraine Disorders

Health Technology Assessment (HTA) Database.2010

133. Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis

Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis Medical Advisory Secretariat Citation Medical Advisory Secretariat. Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis. Toronto: Medical Advisory Secretariat (MAS). Volume 10(26). 2010 Authors' objectives The objectives (...) of this evidence based review are:
To determine the effectiveness of computed tomography (CT) and magnetic resonance imaging (MRI) scans in the evaluation of persons with a chronic headache and a normal neurological examination.
To determine the comparative effectiveness of CT and MRI scans for detecting significant intracranial abnormalities in persons with chronic headache and a normal neurological exam.
To determine the budget impact of CT and MRI scans for persons with a chronic headache and

Health Technology Assessment (HTA) Database.2010

134. High-Risk Headache in the Emergency Department

High-Risk Headache in the Emergency Department High-Risk Headache in the Emergency Department – TheNNTTheNNT Risk Assessment: High-Risk Headache in the Emergency Department 1 in 200 After Negative Head CT If the patient meets the below criteria for this assessment: After a negative head CT: 99.5% did not have a hemorrhage 0.5% did have a (subarachnoid) hemorrhage In Other Words: After a CT scan demonstrates no visible hemorrhage , the risk of a subarachnoid hemorrhage was 1 in 200 Risk (...) Assessment Criteria The pre-test probability (prevalence) of brain hemorrhage was 6.5% in these data, a high risk group with headache: headache with syncope, or reaching maximal intensity within 1 hour Began within last 2 weeks Neurologically normal Source Document: Narrative: Headache is an extremely common problem in outpatient cohorts and a small proportion of patients who are neurologically normal will have brain hemorrhages caused by leaking aneurysms that require repair. Reliably predicting which

theNNT2010

135. Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review

Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review Verhagen AP, Damen L, Berger MY, Passchier J, Koes BW CRD summary This review concluded that evidence for the efficacy or effectiveness of prophylactic drugs for tension-type headache showed that they were (...) not clearly better than placebo. This conclusion clearly reflected the results of a generally well-conducted review and appears likely to be reliable. Authors' objectives To assess the efficacy and tolerability of prophylactic drugs for chronic tension-type headache in adults. Searching MEDLINE, CINAHL, EMBASE and The Cochrane Library were searched from inception to August 2009. Search terms were reported. References of included studies and reviews were checked. There were no language restrictions. Study

DARE.2010

136. Zolmitriptan for acute migraine headaches in adults.

Zolmitriptan for acute migraine headaches in adults. This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of zolmitriptan compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Cochrane2010

137. Eletriptan for acute migraine headaches in adults.

Eletriptan for acute migraine headaches in adults. This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of eletriptan compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Cochrane2010

138. Rizatriptan for acute migraine headaches in adults.

Rizatriptan for acute migraine headaches in adults. This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of rizatriptan compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Cochrane2010

139. Topiramate to Prevent Pediatric Migraine Headaches: A Systematic Review

Topiramate to Prevent Pediatric Migraine Headaches: A Systematic Review "Topiramate to Prevent Pediatric Migraine Headaches: A Systematic Revie" by Tammy L. Wilson < > > > > > Title Author Date of Award 10-2010 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Torry Cobb Rights . Abstract Objectives: Neurogenic inflammation plays a key part in the development and continuation of migraine headaches. Treatment of migraines includes acute (...) of Systematic Reviews, ACP Journal Club, and Cochrane Central Register of Controlled Trials for potential randomized, double-blind, placebo-controlled, parallel studies was conducted to discover studies connected to the question. Results: A pooled analysis of three trials involving 307 patients suggest a moderate benefit when topiramate is given to children between 6 and 17 for prevention of migraine headaches. The decrease in migraine frequency reported by was statistically significant in two

Pacific University EBM Capstone Project2010

140. Acute and preventive pharmacologic treatment of cluster headache

Acute and preventive pharmacologic treatment of cluster headache Acute and preventive pharmacologic treatment of cluster headache | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share August 03, 2010 ; 75 (5) Views and Reviews Acute and preventive pharmacologic treatment of cluster headache George J. Francis , Werner J. Becker and Tamara M. Pringsheim First published August (...) 2, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181eb58c8 George J. Francis Werner J. Becker Tamara M. Pringsheim Acute and preventive pharmacologic treatment of cluster headache George J. Francis , Werner J. Becker , Tamara M. Pringsheim Neurology Aug 2010, 75 (5) 463-473; DOI: 10.1212/WNL.0b013e3181eb58c8 Citation Manager Formats Downloads 2998 Share This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article

American Academy of Neurology2010